pCDNA3.0_nucNanobody IRES EGFP Citations (2)
Originally described in: Chemogenetic Control of Nanobodies.Farrants H, Tarnawski M, Muller TG, Otsuka S, Hiblot J, Koch B, Kueblbeck M, Krausslich HG, Ellenberg J, Johnsson K Nat Methods. 2020 Feb 17. pii: 10.1038/s41592-020-0746-7. doi: 10.1038/s41592-020-0746-7. PubMed Journal
Articles Citing pCDNA3.0_nucNanobody IRES EGFP
| Articles |
|---|
| Rapid and inducible mislocalization of endogenous TDP43 in a novel human model of amyotrophic lateral sclerosis. Ganssauge J, Hawkins S, Namboori SC, Leung SK, Mill J, Bhinge A. Elife. 2025 Jul 24;13:RP95062. doi: 10.7554/eLife.95062. PubMed |
| Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral Protein Degradation. Pan MY, Lee TH, Peng TN, Wu EY, Chiu YT, Chiu CC, Nguyen HV, Pao YS, Chao MH, Lee RK, Wu HC, Wang LH. Adv Sci (Weinh). 2026 Sep;13(53):e76687. doi: 10.1002/advs.76687. Epub 2026 Jul 17. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.